EVGN
Price:
$0.5839
Market Cap:
$4.94M
Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform. This platform, built on deep biological insights, big data analytics, and artificial intelligence, is engineered to digitally identify and strategically guide the creation of life-science solutions derived from microbes, small molecules, and genetic components. The company's operations are structured into three primary divisions: Agriculture, Human Health, and Industrial Application...[Read more]
Industry
Biotechnology
IPO Date
2010-10-15
Stock Exchange
NASDAQ
Ticker
EVGN
According to Evogene Ltd.’s latest financial reports and current stock price. The company's current ROE is 937.72%. This represents a change of -47.70% compared to the average of 1.79% of the last 4 quarters.
The mean historical ROE of Evogene Ltd. over the last ten years is 1.09%. The current 937.72% ROE has changed -14.23% with respect to the historical average. Over the past ten years (40 quarters), EVGN's ROE was at its highest in in the December 2025 quarter at 6.47%. The ROE was at its lowest in in the June 2024 quarter at -176.69%.
Average
1.09%
Median
-39.80%
Minimum
-198.12%
Maximum
10.35%
Discovering the peaks and valleys of Evogene Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 810.79%
Maximum Annual ROE = 10.35%
Minimum Annual Increase = -673.46%
Minimum Annual ROE = -198.12%
| Year | ROE | Change |
|---|---|---|
| 2025 | 10.35% | 810.79% |
| 2024 | 1.14% | -673.46% |
| 2023 | -198.12% | 85.41% |
| 2022 | -106.85% | 89.63% |
| 2021 | -56.35% | -1.00% |
| 2020 | -56.91% | 49.30% |
| 2019 | -38.12% | -8.08% |
| 2018 | -41.47% | 38.08% |
| 2017 | -30.04% | 33.82% |
| 2016 | -22.44% | 35.29% |
The current ROE of Evogene Ltd. (EVGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.76%
5-year avg
2.22%
10-year avg
1.09%
Evogene Ltd.’s ROE is greater than Sensei Biotherapeutics, Inc. (-283.67%), greater than Imunon, Inc. (-341.23%), greater than Cocrystal Pharma, Inc. (-150.61%), greater than Marker Therapeutics, Inc. (-73.29%), greater than Bolt Biotherapeutics, Inc. (-100.90%), greater than Cellectar Biosciences, Inc. (-264.79%), greater than Dogwood Therapeutics, Inc. (-35.91%), less than AEON Biopharma, Inc. (223.66%), greater than Galecto, Inc. (-122.61%), greater than Cingulate Inc. (-365.16%),
| Company | ROE | Market cap |
|---|---|---|
| -283.67% | $17.45M | |
| -341.23% | $5.09M | |
| -150.61% | $10.20M | |
| -73.29% | $14.90M | |
| -100.90% | $8.76M | |
| -264.79% | $7.12M | |
| -35.91% | $2.94M | |
| 223.66% | $8.64M | |
| -122.61% | $34.47M | |
| -365.16% | $27.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evogene Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Evogene Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Evogene Ltd.'s ROE?
How is the ROE calculated for Evogene Ltd. (EVGN)?
What is the highest ROE for Evogene Ltd. (EVGN)?
What is the 3-year average ROE for Evogene Ltd. (EVGN)?
What is the 5-year average ROE for Evogene Ltd. (EVGN)?
How does the current ROE for Evogene Ltd. (EVGN) compare to its historical average?